Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lithium Ionic Awarded Water Rights for Bandeira Lithium Project, Minas Gerais, Brazil
-
Enviri Corporation Reports First Quarter 2024 Results
-
Atlas Opens New San Diego Office
-
Agios Reports Business Highlights and First Quarter 2024 Financial Results
-
Quell Therapeutics Highlights Clinical Potential of QEL-001 and its Multi-Modular Treg Cell Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
-
Axogen, Inc Reports First Quarter 2024 Financial Results
-
Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
-
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
-
BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline
-
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
-
Colliers Reports First Quarter Results
-
Athira Pharma to Participate in Upcoming May Conferences
-
Plug Continues to Expand Cryogenic Sales with Multiple Customer Agreements and International Expansion
-
Arqit and SoftIron Partner to sell more secure data center deployments
-
PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Target for Green Cement Additive Product
-
Lantheus Reports First Quarter 2024 Financial Results
-
Malibu Boats, Inc. Announces Third Quarter Fiscal 2024 Results
-
Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage
-
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
-
Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference
-
Comic Book Fans Rally for Children International:
-
Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
-
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
-
Alta Equipment Group Announces Common Stock Dividend
-
Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
-
Alpha Transform Holdings Announces Strategic Investments in AI
-
insightsoftware Recognized as DACH Region Market Leader for Sixth Consecutive Year in BARC Score Financial Performance Management Report
-
Arvinas to Present at Upcoming Investor Conferences
-
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
-
Flashtalking by Mediaocean named Leader in 2024 SPARK Matrix for AdTech by Quadrant Knowledge Solutions
-
Masterworks Surpasses $1 Billion In Capital Raised
-
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024
-
FactSet Increases Dividend
-
Quell Therapeutics Highlights Clinical Potential of QEL-001 and its Multi-Modular Treg Cell Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
-
Fenix Outdoor: Q1 report Fenix Outdoor International AG
-
Pneumagen to Present Phase 2 Clinical Data on Neumifil, its Broad-Spectrum Antiviral, Intranasal Drug for Viral Respiratory Tract Infections, at ATS 2024
-
YieldMax™ Launches Short TSLA Option Income Strategy ETF CRSH
-
Ocwen Financial Announces First Quarter 2024 Results
-
OLAPLEX Reports First Quarter 2024 Results
-
Call for Nominations Open for “Educators Pick Best of STEM® 2024 Awards”
-
BlackDice's Deployment Progress and Investor Outlook for Q2 2024
-
Azimut Sells to Patriot Battery Metals its JBN-57 Property, James Bay Region, Quebec
-
Record Results by Willis Lease Finance Corporation with First Quarter Pre-tax Income of $29.9 million
-
Beyond, Inc. Announces Key Additions to Leadership Team
-
eGain Announces Webinar on Gen AI for Service, Featuring Success Story from Leading Utility Client
-
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
-
SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
-
Apollo Reports First Quarter 2024 Results
-
Regeneron Reports First Quarter 2024 Financial and Operating Results
-
Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings
